American Medical ID broadens reach with added distribution
HOUSTON — American Medical ID has expanded its reach by offering its medical identification bracelets and necklaces at three major drug stores.
The company said that beginning this month, its products now are available at 5,800 CVS locations, 7,200 Walgreens locations and 4,800 Rite Aid locations.
“It is wonderful to be working with these leading retail pharmacies who have a strong commitment to helping their customers stay healthy. They understand the importance and need for medical IDs and strive to make these life saving tools more accessible for their customers,” American Medical ID president and CEO Rick Russell said.
U.S. District Court blocks Mylan’s generic antibiotic
DUBLIN — A federal court in New Jersey has blocked an attempt by Mylan to market a generic version of a drug made by Warner Chilcott.
Warner Chilcott announced Thursday that the U.S. District Court for the District of New Jersey granted its motion for a preliminary injunction against Mylan to prevent it from launching a generic version of the antibiotic Doryx (doxycycline) in the 150-mg strength until the court makes a decision relating to a patent covering the drug, which Warner Chilcott and Mayne Pharmaceuticals allege Mylan to have infringed.
According to IMS Health, Doryx in the 150-mg strength represents more than 95% of Warner Chilcott’s entire Doryx franchise based on total prescriptions.
Report: J&J resumes shipping of Tylenol product
NEW YORK — It seems that Tylenol Cold & Flu Severe caplets are making their way back to store shelves, according to published reports.
According to several reports, McNeil Consumer Healthcare spokeswoman Bonnie Jacobs confirmed that the product, which is designated for adult use, will begin shipping this week.
McNeil Consumer Healthcare, a Johnson & Johnson subsidiary, recalled several lots of Tylenol products due to reports of uncharacteristic odor, which was linked to the presence of trace amounts of a chemical known as 2,4,6-tribromoanisole (TBA).
Back in February, J&J executives said McNeil Consumer’s absence from cough-cold and analgesic aisles, including several pediatric formulations, would extend into the fourth quarter.